Center for Scientific Review; Notice of Closed Meetings, 26061-26062 [2021-10020]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 90 / Wednesday, May 12, 2021 / Notices
Agenda: Group Discussion of
Opportunities and Gaps in Translational
Research.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Rockville,
MD 20850 (Virtual Meeting).
Contact Person: Peter Ujhazy, M.D., Ph.D.,
Deputy Associate Director, Translational
Research Program, Division of Cancer
Treatment and Diagnosis, National Cancer
Institute, National Institutes of Health, 9609
Medical Center Drive, Room 3W106,
Rockville, MD 20850, 240–276–5681,
ujhazyp@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/ctac/
subcommittees/index.htm, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 7, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–10027 Filed 5–11–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
VerDate Sep<11>2014
17:58 May 11, 2021
Jkt 253001
Social Psychology, Personality and
Interpersonal Processes Study Section.
Date: June 10–11, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shalanda A. Bynum,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
Bethesda, MD 20892, 301–755–4355,
bynumsa@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neuroimmunology and Brain Tumors.
Date: June 10, 2021.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Samuel C. Edwards, Ph.D.,
Chief, Brain Disorders and Clinical
Neuroscience, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5210, MSC 7846, Bethesda, MD
20892, (301) 435–1246, edwardss@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Neurodevelopment, Synaptic
Plasticity and Neurodegeneration.
Date: June 14–15, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tina Tze-Tsang Tang,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Suite 3030,
Bethesda, MD 20817, (301) 435–4436, tangt@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Membrane
Biology and Protein Processing.
Date: June 14, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maqsood A. Wani, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2114,
MSC 7814, Bethesda, MD 20892, 301–435–
2270, wanimaqs@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Macromolecular Structure
and Function B Study Section.
Date: June 15–16, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
26061
Contact Person: C–L Albert Wang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4146,
MSC 7806, Bethesda, MD 20892, 301–435–
1016, wangca@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Surgery,
Anesthesiology and Trauma Study Section.
Date: June 15–16, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weihua Luo, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114,
MSC 7854, Bethesda, MD 20892, (301) 435–
1170, luow@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Kidney and Urological Systems Function and
Dysfunction Study Section.
Date: June 17–18, 2021.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ganesan Ramesh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, 301–827–
5467, ganesan.ramesh@nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Imaging
Technology Development Study Section.
Date: June 17–18, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ileana Hancu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5116,
Bethesda, MD 20817, 301–402–3911,
ileana.hancu@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Lifestyle
Change and Behavioral Health.
Date: June 17, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weijia Ni, Ph.D., MA, BA,
Chief/Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3100,
MSC 7808, Bethesda, MD 20892, (301) 594–
3292, niw@csr.nih.gov.
Name of Committee: Infectious Diseases
and Immunology B Integrated Review Group;
E:\FR\FM\12MYN1.SGM
12MYN1
26062
Federal Register / Vol. 86, No. 90 / Wednesday, May 12, 2021 / Notices
Hypersensitivity, Autoimmune, and Immunemediated Diseases Study Section.
Date: June 17–18, 2021.
Time: 10:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Deborah Hodge, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4207,
MSC 7812, Bethesda, MD 20892, (301) 435–
1238, hodged@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 7, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–10020 Filed 5–11–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[Docket No. FWS–R5–ES–2020–0098;
FXES11130500000–212–FF05E00000]
Endangered and Threatened Wildlife
and Plants; Draft Recovery Plan for the
Rufa Red Knot
Fish and Wildlife Service,
Interior.
ACTION: Notice of availability and
request for public comment.
AGENCY:
We, the U.S. Fish and
Wildlife Service, announce the
availability of the draft recovery plan for
rufa red knot, a bird subspecies listed as
threatened under the Endangered
Species Act. We request review and
comment on this draft recovery plan
from local, State, and Federal agencies,
and the public.
DATES: We must receive comments by
July 12, 2021.
ADDRESSES:
Document availability: The draft
recovery plan, along with any comments
and other materials that we receive, will
be available for public inspection at
https://www.regulations.gov in Docket
No. FWS–R5–ES–2020–0098.
Submitting Comments: You may
submit comments by one of the
following methods:
• Internet: https://
www.regulations.gov. Search for and
submit comments on Docket No. FWS–
R5–ES–2020–0098.
• U.S. Mail: Public Comments
Processing, Attn: Docket No. FWS–R5–
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:58 May 11, 2021
Jkt 253001
ES–2020–0098; U.S. Fish and Wildlife
Service Headquarters, MS: PRB/3W;
5275 Leesburg Pike; Falls Church, VA
22041–3803.
For more information, see Availability
of Public Comments under
SUPPLEMENTARY INFORMATION.
FOR FURTHER INFORMATION CONTACT: Eric
Schrading, Field Supervisor by phone at
609–382–5272, via email at eric_
schrading@fws.gov, or via the Federal
Relay Service at 800–877–8339.
SUPPLEMENTARY INFORMATION: We, the
U.S. Fish and Wildlife Service (Service),
announce the availability of the draft
recovery plan for the threatened rufa red
knot (Calidris canutus rufa) for public
review and comment. The draft recovery
plan includes objective, measurable
criteria and management actions as may
be necessary for removal of the species
from the Federal List of Endangered and
Threatened Wildlife. We request review
and comment on this draft recovery
plan from local, State, and Federal
agencies, and the public.
coastal and inland staging areas and an
ample supply of other coastal and
inland stopover habitats distributed
across the range. In the final listing rule
published on December 12, 2014 (79 FR
73705), the Service determined that the
rufa red knot is threatened under the
ESA due to the following primary
threats: Loss of breeding and
nonbreeding habitat (including sea level
rise, coastal engineering, coastal
development, and arctic ecosystem
change); likely effects related to
disruption of natural predator cycles on
the breeding grounds; reduced prey
availability throughout the nonbreeding
range; and increasing frequency and
severity of asynchronies (mismatches)
in the timing of the birds’ annual
migratory cycle relative to favorable
food and weather conditions. Refer to
the Species Status Assessment Report
(USFWS 2020) for a full discussion of
the species’ biology and threats.
Recovery Planning
The recovery strategy is to prevent
loss of the rufa red knot’s adaptive
capacity by maintaining representation
within and among four Recovery Units,
and improving their resiliency and
redundancy. Recovery efforts will focus
on protecting, restoring, maintaining,
and managing important nonbreeding
habitats for adults and juveniles.
Recovery actions will directly abate
threats to red knots in their wintering
and migration ranges, and will also
increase resiliency of populations to
withstand threats that stem from climate
change in their Arctic breeding range
and elsewhere. These actions include
monitoring and safeguarding ample food
supplies; preventing impacts from
development and shoreline
stabilization; managing human
disturbance; and restoring key habitats.
They may also include land acquisition,
facilitated migration of certain beaches
or tidal flats, and restoring natural
coastal processes that create and
maintain red knot habitat.
Section 4(f) of the Endangered Species
Act of 1973, as amended (Act; 16 U.S.C.
1531 et seq.), requires the development
of recovery plans for listed species,
unless such a plan would not promote
the conservation of a particular species.
Also pursuant to section 4(f) of the Act,
a recovery plan must, to the maximum
extent practicable, include (1) a
description of site-specific management
actions as may be necessary to achieve
the plan’s goals for the conservation and
survival of the species; (2) objective,
measurable criteria that, when met,
would support a determination under
section 4(a)(1) that the species should be
removed from the List of Endangered
and Threatened Species; and (3)
estimates of the time and costs required
to carry out those measures needed to
achieve the plan’s goal.
Species Background
The rufa red knot is a medium-sized,
highly migratory shorebird that ranges
across nearly the full latitude gradient of
the Western Hemisphere. This
subspecies is among the longestdistance migrants in the animal
kingdom, and among the best-studied
shorebirds in the world. Rufa red knots
migrate annually between their breeding
grounds on the central Canadian arctic
tundra and four wintering regions that
include the Atlantic coasts of Argentina
and Chile, the northern coast of South
America, the western Gulf of Mexico,
and the southeast United States and the
Caribbean. During migration, rufa red
knots require a reliable network of
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Recovery Strategy
Availability of Public Comments
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
E:\FR\FM\12MYN1.SGM
12MYN1
]]>Agencies
[Federal Register Volume 86, Number 90 (Wednesday, May 12, 2021)]
[Notices]
[Pages 26061-26062]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-10020]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Risk, Prevention and Health Behavior
Integrated Review Group; Social Psychology, Personality and
Interpersonal Processes Study Section.
Date: June 10-11, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shalanda A. Bynum, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206, Bethesda, MD 20892, 301-
755-4355, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neuroimmunology and Brain Tumors.
Date: June 10, 2021.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Samuel C. Edwards, Ph.D., Chief, Brain Disorders
and Clinical Neuroscience, Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive, Room 5210, MSC 7846,
Bethesda, MD 20892, (301) 435-1246, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Neurodevelopment, Synaptic Plasticity and
Neurodegeneration.
Date: June 14-15, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tina Tze-Tsang Tang, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Suite 3030, Bethesda, MD 20817, (301)
435-4436, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Membrane Biology and Protein Processing.
Date: June 14, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maqsood A. Wani, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2114, MSC 7814, Bethesda, MD
20892, 301-435-2270, [email protected].
Name of Committee: Biological Chemistry and Macromolecular
Biophysics Integrated Review Group; Macromolecular Structure and
Function B Study Section.
Date: June 15-16, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: C-L Albert Wang, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4146, MSC 7806, Bethesda, MD
20892, 301-435-1016, [email protected].
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group; Surgery, Anesthesiology and
Trauma Study Section.
Date: June 15-16, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weihua Luo, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114, MSC 7854, Bethesda, MD
20892, (301) 435-1170, [email protected].
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group; Kidney and Urological Systems Function and
Dysfunction Study Section.
Date: June 17-18, 2021.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ganesan Ramesh, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182, MSC 7818, Bethesda, MD
20892, 301-827-5467, [email protected].
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group; Imaging Technology
Development Study Section.
Date: June 17-18, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ileana Hancu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5116, Bethesda, MD 20817, 301-402-3911,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Lifestyle Change and Behavioral Health.
Date: June 17, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Weijia Ni, Ph.D., MA, BA, Chief/Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3100, MSC 7808, Bethesda, MD
20892, (301) 594-3292, [email protected].
Name of Committee: Infectious Diseases and Immunology B
Integrated Review Group;
[[Page 26062]]
Hypersensitivity, Autoimmune, and Immune-mediated Diseases Study
Section.
Date: June 17-18, 2021.
Time: 10:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Deborah Hodge, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4207, MSC 7812, Bethesda, MD 20892, (301) 435-
1238, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 7, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-10020 Filed 5-11-21; 8:45 am]
BILLING CODE 4140-01-P
